You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 13, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Göran Dahl1, Stephan Steigele2, Per Hillertz3
11 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Mölndal, Sweden.
A new software module streamlines surface plasmon resonance (SPR) data analysis in drug discovery. This automated workflow enhances efficiency and quality control for molecular interaction studies.
06:12Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023
15:27Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: